COPB2-DT: A Drug Target / Disease Biomarker (G100507291)

Target Name: COPB2-DT

NCBI ID: G100507291

COPB2-DT

Other Name(s): COPB2 divergent transcript, transcript variant 1 | COPB2-DT variant 1 | COPB2 divergent transcript

COPB2-DT: A Drug Target / Disease Biomarker

COPB2-DT is a protein that is expressed in the brain and is involved in the regulation of breathing and heart rate. It is a potential drug target for the treatment of a variety of neurological and cardiovascular conditions.

The breathing and heart rate are critical functions that require the coordinated activity of multiple muscles and nerves. COPB2-DT plays a key role in regulating these functions by controlling the movement of the diaphragm, a muscle that separates the chest and abdominal cavities.

COPB2-DT is a protein that is produced by the body's immune system. It is expressed in the brain and is involved in the regulation of breathing and heart rate.

One of the functions of COPB2-DT is to regulate the movement of the diaphragm. The diaphragm is a large muscle that separates the chest and abdominal cavities. It is responsible for expanding and contracting the lungs to allow for the exchange of oxygen and carbon dioxide.

COPB2-DT helps to regulate the movement of the diaphragm by controlling the strength and timing of its contractions. This is important for maintaining proper breathing and heart rate.

In addition to its role in regulating breathing and heart rate, COPB2-DT is also involved in the regulation of other physiological processes that are critical for the health and function of the brain.

For example, COPB2-DT is involved in the regulation of the production and release of neurotransmitters, which are chemical messengers that are used by the brain to communicate with other cells and to regulate various physiological processes.

COPB2-DT is also involved in the regulation of the formation and function of blood vessels in the brain, which is important for delivering oxygen and nutrients to the brain.

In addition to its role in regulating physiological processes, COPB2-DT is also thought to be involved in the development and progression of certain neurological and cardiovascular conditions.

For example, studies have suggested that COPB2-DT may be involved in the development of Alzheimer's disease, a condition that is characterized by the progressive loss of memory and other cognitive functions.

In addition, COPB2-DT has also been implicated in the development and progression of other cardiovascular conditions, such as heart failure and hypertension.

Given its involvement in the regulation of breathing and heart rate, as well as its potential role in the development and progression of certain neurological and cardiovascular conditions, COPB2-DT is a promising drug target for the treatment of a variety of conditions.

In conclusion, COPB2-DT is a protein that is expressed in the brain and is involved in the regulation of breathing and heart rate. It is a potential drug target for the treatment of a variety of neurological and cardiovascular conditions. Further research is needed to fully understand the role of COPB2-DT in these processes and to develop effective treatments.

Protein Name: COPB2 Divergent Transcript

The "COPB2-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about COPB2-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets